Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.87
Delayed Data
As of 4:00pm ET
 -0.0168 / -1.89%
Today’s Change
0.85
Today|||52-Week Range
3.65
-61.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues19.6M7.7M20.8M1.2M
 
 
 
 
 
Depreciation And Amortization1.4M1.5M1.6M2.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses36.0M51.1M73.9M80.4M
 
 
 
 
 
Research And Development29.9M41.0M56.4M64.3M
 
 
 
 
 
Total Operating Expenses37.4M52.6M75.5M82.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.8M-44.9M-54.8M-81.5M
 
 
 
 
 
Extraordinary Charge-1.1M-12.1M-1.8M0.00
 
 
 
 
Interest Expense On Debt36.0K39.0K52.0K1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.7M-56.7M-55.8M-81.8M
 
 
 
 
 
Income Taxes-23.0K-1.0K-18.0K-4.0K
 
 
 
 
 
Net Income-18.7M-56.7M-55.7M-81.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS38.5M44.1M51.4M52.8M
 
 
 
 
 
Shares To Calculate EPS Diluted38.5M44.1M51.4M52.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.49-$1.29-$1.08-$1.55
 
 
 
 
 
EPS Diluted-$0.49-$1.29-$1.08-$1.55